| SC 13D/A | 2013-07-11 | BAKER BROS. ADVISORS LP | MEI Pharma, Inc. | 1,215,612 | 6.8% | EDGAR |
| SC 13D/A | 2013-06-14 | VIVO VENTURES VII, LLC | MEI Pharma, Inc. | 4,407,095 | 25.1% | EDGAR |
| SC 13D/A | 2013-05-15 | New Leaf Ventures II, L.P. | MEI Pharma, Inc. | 4,145,475 | 21.6% | EDGAR |
| SC 13G | 2013-03-11 | FMR LLC | MEI Pharma, Inc. | 1,896,851 | 12.6% | EDGAR |
| SC 13D/A | 2013-03-05 | BAKER BROS ADVISORS LLC | MEI Pharma, Inc. | 1,200,000 | 7.6% | EDGAR |
| SC 13D/A | 2013-03-01 | New Leaf Ventures II, L.P. | MEI Pharma, Inc. | 4,602,775 | 26.9% | EDGAR |
| SC 13D/A | 2013-02-27 | BAKER BROS ADVISORS LLC | MEI Pharma, Inc. | 1,427,017 | 9.1% | EDGAR |
| SC 13G/A | 2013-02-14 | OPPENHEIMER FUNDS INC | MEI Pharma, Inc. | 614,603 | 4.5% | EDGAR |
| SC 13G/A | 2013-02-14 | RA CAPITAL MANAGEMENT, LLC | MEI Pharma, Inc. | 991,666 | 6.6% | EDGAR |
| SC 13G/A | 2013-02-13 | CAPITAL VENTURES INTERNATIONAL /E9/ | MEI Pharma, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2013-02-06 | Hudson Bay Capital Management LP | MEI Pharma, Inc. | - | 1.2% | EDGAR |
| SC 13G | 2013-01-03 | RA CAPITAL MANAGEMENT, LLC | MEI Pharma, Inc. | 991,666 | 7.0% | EDGAR |
| SC 13D | 2012-12-21 | VIVO VENTURES VII, LLC | MEI Pharma, Inc. | 4,660,796 | 33.0% | EDGAR |
| SC 13D/A | 2012-12-17 | AUSTIN JOSIAH T | MEI Pharma, Inc. | 4,216,913 | 15.7% | EDGAR |
| SC 13D | 2012-12-10 | New Leaf Ventures II, L.P. | MEI Pharma, Inc. | 30,600,000 | 32.5% | EDGAR |
| SC 13D/A | 2012-12-07 | NOVOGEN LTD | MEI Pharma, Inc. | 42,107 | 0.2% | EDGAR |
| SC 13D | 2012-11-13 | BAKER BROS ADVISORS LLC | MEI Pharma, Inc. | 7,840,000 | 10.0% | EDGAR |
| SC 13D/A | 2012-10-19 | NOVOGEN LTD | MEI Pharma, Inc. | 20,084,414 | 69.9% | EDGAR |
| SC 13D/A | 2012-05-25 | NOVOGEN LTD | MARSHALL EDWARDS INC | 20,084,454 | 72.8% | EDGAR |
| SC 13G/A | 2012-02-14 | CAPITAL VENTURES INTERNATIONAL /E9/ | MARSHALL EDWARDS INC | 1,475,666 | 9.9% | EDGAR |